All news

JPMorgan upgrades Welltower to Overweight on strong results

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

JPMorgan upgraded Welltower (NYSE: WELL) to Overweight with a USD 260.00 price target, following strong second-quarter 2026 results. Normalized FFO rose 25.00 percent to USD 1.60 per share and revenue climbed 39.10 percent to USD 3.54 billion. The healthcare facilities REIT also posted growth in Seniors Housing Operating net operating income and occupancy.

Read original source

WELL company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.